de Craecker Francoise 4
4 · X4 Pharmaceuticals, Inc · Filed Oct 18, 2021
Insider Transaction Report
Form 4
de Craecker Francoise
Director
Transactions
- Award
Stock Option (right to buy)
2021-10-14+12,250→ 12,250 totalExercise: $5.37Exp: 2031-10-13→ Common Stock (12,250 underlying)
Footnotes (1)
- [F1]33.3333% of the shares subject to the option shall vest on October 14, 2022, with the remainder vesting thereafter in equal monthly installments of 2.7777% of the shares subject to the option until the 36-month anniversary of the date of the grant, subject to the Reporting Person's continued services as a director through each applicable vesting date.